Postdoc PET-SPECT instrumentation for cancer therapy research
Updated: 01 Dec 2022
Imaging distributions of radiolabeled molecules using PET and SPECT scaners is key for discovering mechanisms of disease, new pharmaceuticals and diagnostic tracers. The application of radiotracers that combine a predictive biomarker with a therapeutic agent -theranostic tracers– and the demand for multi-tracer imaging are witnessing an impressive growth. The postdoc will be part of a project that aims at developing a novel small animal PET-SPECT scanner that
- enables improved quantitative tomography for virtually any available gamma, positron or co-emitting tracer molecule (30 keV - 1 MeV energy range),
- allows quantitative imaging of many new tracer combinations including multiple PET isotopes, and
- has an order of magnitude higher effective sensitivity for high-energy gamma emitters than current scanners.
To enable such universal molecular nuclear tomography platform the postdoc will explore (1) innovative collimator designs (2) image reconstruction with universal energy-dependent models for high-energy and co-emitting gamma and positron emitters (3) utilization of new detectors.
The applicants should have a PhD in medical imaging or another relevant direction. Experience with conducting imaging experiments and developing image reconstruction or simulation software is preferred. The candidates will work in a highly multi-disciplinary team. Good communication skills and an excellent command of English, both written and spoken, are important.
Salary and benefits are in accordance with the Collective Labour Agreement for Dutch Universities. The TU Delft offers a customisable compensation package, a discount on health insurance and sport memberships, and a monthly work costs contribution. Flexible work schedules can be arranged.
38 hours per week